Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Deloitte
Baxter
Colorcon
Citi
UBS
Mallinckrodt
Queensland Health
Farmers Insurance

Generated: August 20, 2018

DrugPatentWatch Database Preview

West-ward Pharms Int Company Profile

« Back to Dashboard

What is the competitive landscape for WEST-WARD PHARMS INT, and what generic and branded alternatives to WEST-WARD PHARMS INT drugs are available?

WEST-WARD PHARMS INT has three hundred and sixty-one approved drugs.

There is one tentative approval on WEST-WARD PHARMS INT drugs.

Summary for West-ward Pharms Int
US Patents:0
Tradenames:236
Ingredients:211
NDAs:361

Drugs and US Patents for West-ward Pharms Int

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int AZATHIOPRINE SODIUM azathioprine sodium INJECTABLE;INJECTION 074419-001 Mar 31, 1995 RX No Yes ➤ Sign Up ➤ Sign Up
West-ward Pharms Int LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 077459-002 Oct 6, 2010 AB RX No No ➤ Sign Up ➤ Sign Up
West-ward Pharms Int CLINDAMYCIN PHOSPHATE clindamycin phosphate INJECTABLE;INJECTION 062889-001 Apr 25, 1988 AP RX No No ➤ Sign Up ➤ Sign Up
West-ward Pharms Int LEUCOVORIN CALCIUM PRESERVATIVE FREE leucovorin calcium INJECTABLE;INJECTION 040056-001 May 23, 1995 AP RX No Yes ➤ Sign Up ➤ Sign Up
West-ward Pharms Int HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 017037-013 Apr 7, 1986 DISCN No No ➤ Sign Up ➤ Sign Up
West-ward Pharms Int CYTARABINE cytarabine INJECTABLE;INJECTION 071472-001 Aug 2, 1989 RX No Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for West-ward Pharms Int

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-003 Sep 30, 1982 4,110,438 ➤ Sign Up
West-ward Pharms Int REGLAN metoclopramide hydrochloride INJECTABLE;INJECTION 017862-001 Approved Prior to Jan 1, 1982 4,536,386 ➤ Sign Up
West-ward Pharms Int ATIVAN lorazepam INJECTABLE;INJECTION 018140-001 Approved Prior to Jan 1, 1982 4,017,616 ➤ Sign Up
West-ward Pharms Int REGLAN metoclopramide hydrochloride INJECTABLE;INJECTION 017862-004 May 28, 1987 4,536,386 ➤ Sign Up
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-002 Sep 30, 1982 3,947,569 ➤ Sign Up
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-001 Sep 30, 1982 3,947,569 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for WEST-WARD PHARMS INT drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 1 mg ➤ Subscribe 2009-08-14
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
Johnson and Johnson
Farmers Insurance
Accenture
Healthtrust
Queensland Health
Julphar
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.